 Patients will be randomized 1:1 to receive the intervention at study start or delayed appointment 6 months later. The intervention includes initial baseline data collection from the patient including data on demographics, medications, and illness characteristics. The patient will then attend an appointment with a pharmacist to review medications appropriate for discontinuationdose reduction, after which the patient will meet with hisher family physician to discuss patient preferences for discontinuationdose reduction. Follow up appointments will take place at one week, 3 months and 6 months study end. Questionnaires and a semi-structured interview will take place at the 6 month appointment. After six months, the control group will be offered the intervention. 